Compare LSBK & ASRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LSBK | ASRT |
|---|---|---|
| Founded | 1891 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 110.0M | 75.1M |
| IPO Year | 2006 | 1997 |
| Metric | LSBK | ASRT |
|---|---|---|
| Price | $14.86 | $9.35 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $35.00 |
| AVG Volume (30 Days) | 8.0K | ★ 55.3K |
| Earning Date | 01-23-2026 | 11-10-2025 |
| Dividend Yield | ★ 2.43% | N/A |
| EPS Growth | ★ 105.28 | N/A |
| EPS | ★ 1.21 | N/A |
| Revenue | $27,774,000.00 | ★ $137,354,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $12.26 | ★ N/A |
| Revenue Growth | ★ 9.61 | 9.22 |
| 52 Week Low | $11.50 | $7.71 |
| 52 Week High | $16.95 | $15.15 |
| Indicator | LSBK | ASRT |
|---|---|---|
| Relative Strength Index (RSI) | 58.28 | 86.13 |
| Support Level | $14.66 | $8.61 |
| Resistance Level | $14.98 | $9.87 |
| Average True Range (ATR) | 0.20 | 0.38 |
| MACD | -0.03 | 0.68 |
| Stochastic Oscillator | 77.98 | 88.99 |
Lake Shore Bancorp Inc operates as a savings and loan holdings company. The bank's business consists of attracting retail deposits from the general public in the areas surrounding its branch offices and investing those deposits, together with funds generated from operations, in commercial real estate loans, one-to-four family residential mortgage loans, home equity lines of credit and to a lesser extent, commercial business loans, consumer loans, and investment securities. Its revenues are principally derived from interest earned on loans and investment securities.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.